Need to reduce lactation; some types of infertility, breast problems and menstrual disorders.
Since dopaminergic stimulation may lead to symptoms of orthostatic hypotension, the dosage of quinagolide should be initiated gradually with the aid of the 'starter pack', and given only at bedtime.The optimal dose must be titrated individually on the basis of the prolactin-lowering effect and tolerability. With the 'starter pack' treatment begins with 25mcg/day for the first 3 days, followed by 50mcg/day for a further 3 days. From day 7 onwards, the recommended dose is 75mcg/day. If necessary, the daily dose may then be increased stepwise until the optimal individual response is attained. The usual maintenance dosage is 75 to 150 mcg/day. Daily doses of 300 mcg or higher doses are required in less than one-third of the patients. In such cases, the daily dosage may be increased in steps of 75 to 150mcg at intervals not shorter than 4 weeks until satisfactory therapeutic effectiveness is achieved or reduced tolerability, requiring the discontinuation of treatment, occurs.)
Mode of action
Brands containing this Ingredient
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
It is a prolactin inhibitor that prevents the production of prolactin[prolactin is involved in the processes of milk production and also alter levels of hormones involved with controlling the menstrual cycle and fertility.
Dizziness, tiredness, drowsiness; nausea; vomiting; headache; constipation; diarrhoea; loss of appetite; abdominal pain; difficulty sleeping; increased water retention; flushing; nasal congestion; a drop in blood pressure